GOLDLINE PHARMACEUTICAL LIMITE Share Price

GOLDLINE PHARMACEUTICAL LIMITE Share Price

BSE: 544759
|
Pharmaceuticals
|
S Cap
₹ 34.90
-₹1.70 (-4.64%)
1D
Last updated 18 Sep, 2026, 15:27 IST

GOLDLINE PHARMACEUTICAL LIMITE Share Price Today

As of 18 Sep 2026, GOLDLINE PHARMACEUTICAL LIMITE share price is ₹34.90. The stock opened at ₹35.00, compared to its previous close of ₹36.60. During today's trading session, GOLDLINE PHARMACEUTICAL LIMITE share price moved in the range of ₹34.22 to ₹35.00, with an average price of ₹34.61 for the day. Looking at its last 52-week, the stock has touched a low of ₹33.00 and a high of ₹60.00.

₹34.22
4.64% down today
₹35.00
1D LOW
1D HIGH

GOLDLINE PHARMACEUTICAL LIMITE Returns Calculator

Circuit
L
H
₹29.28
₹43.92
52-week
L
H
₹33.00
₹60.00

About GOLDLINE PHARMACEUTICAL LIMITE

GOLDLINE PHARMACEUTICAL LIMITE Share Price
ISIN
INE1CLW01015
Sector Market Cap
₹ 35.14 Cr

GOLDLINE PHARMACEUTICAL LIMITE Financial Highlights

  • Revenue: GOLDLINE PHARMACEUTICAL LIMITE reported revenue of ₹31.20 crore in FY26 vs ₹28.06 crore in FY25. It showed an increase of 11.19% on a yearly basis.
  • Operating Profit: GOLDLINE PHARMACEUTICAL LIMITE reported an operating profit of ₹5.39 crore in FY26 vs ₹3.86 crore in FY25. It showed an increase of 39.64% on a year-on-year basis.
  • Net Profit: GOLDLINE PHARMACEUTICAL LIMITE reported a net profit of ₹4.12 crore in FY26 vs ₹2.83 crore in FY25. It showed an increase of 45.58% on a yearly basis.
Know more
Promoters
57.29%
FII
5.16%
Other DII
7.81%
Retail and other
29.74%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
May 20265.16%
Mkt Cap Cr
35.14
P/E
0.00
P/B
0.00
ROE
39.26%
D/E
0.82
ROCE
29.32%
Div. Yield
0.00%
EPS(TTM)
5.97
Turnover
1.86
EV/EBITDA
0.00
Net Margin
13.21%
Op. Margin
22.72%
ROA
16.84%
Quick Ratio
1.64
Curr. Ratio
2.06
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Goldline Pharmaceutical has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Goldline Pharmaceutical appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,47,716.0036.955.3613.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,48,120.0084.8314.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,86,038.0086.2922.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,13,451.0024.704.1818.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,858.0033.033.2211.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,05,707.0096.9519.9416.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories97,828.7030.732.5711.07%0.1812.54%377.950.68%0.4138.68
Aurobindo Pharma96,890.8026.112.569.25%0.1911.76%394.820.24%0.3841.58
Lupin95,660.0017.234.2623.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,793.9045.845.8211.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GOLDLINE PHARMACEUTICAL LIMITE Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹31.20₹28.06₹23.57₹19.85
Other Income₹0.00₹0.00₹0.00₹0.00
Total Revenue₹31.20₹28.06₹23.57₹19.85
Total Expenses₹25.81₹24.20₹21.04₹19.45
Profit Before Tax₹5.39₹3.86₹2.53₹0.40
Tax₹1.27₹1.02₹0.72₹0.14
Profit After Tax₹4.12₹2.83₹1.81₹0.26
EPS - Basic₹5.97₹4.11₹3.01₹0.43
EPS - Diluted₹5.97₹4.11₹3.01₹0.43

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.39₹3.86₹2.53₹0.40
Income before WC changes₹6.94₹5.92₹4.35₹2.40
Change in Assets-₹3.41-₹2.56-₹1.91-₹0.52
Change in Liabilities₹0.26₹0.73₹0.69₹0.55
Change in WC-₹3.15-₹1.83-₹1.23₹0.03
Cash flow from Operations₹2.81₹3.18₹2.92₹2.39
Cash flow from Investing-₹0.06₹0.16-₹1.11-₹1.03
Cash flow from Financing-₹3.40-₹2.89-₹1.08-₹1.44
Total Cash Flow-₹0.65₹0.45₹0.74-₹0.09
Cash (Start of the year)₹1.24₹0.79₹0.05₹0.14
Cash (End of the year)₹0.59₹1.24₹0.79₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2.82₹2.93₹3.43₹2.57
Current Assets₹26.05₹23.35₹19.50₹16.82
Total Assets₹28.87₹26.28₹22.93₹19.39
Current Liabilities₹12.11₹11.77₹10.17₹9.00
Net Current Asset₹13.93₹11.58₹9.33₹7.83
Non-Current Liabilities₹2.51₹4.16₹4.90₹4.50
Equity Capital₹14.25₹10.35₹7.87₹5.89
Total Equity & Liabilities₹28.87₹26.28₹22.93₹19.39
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
37.15
Neutral
ATR (14)
1.49
Neutral
STOCH(9,6)
35.95
Neutral
STOCH RSI (14)
3.85
Bullish
ADX(9)
36.27
Bearish
UO(9)
57.87
Neutral
ROC(12)
-8.82
Bearish
WillR(14)
-64.05
Neutral
Period
Simple value
Exponential vaue
5D
37.03
37.16
10D
38.41
37.98
20D
39.32
38.86
50D
40.13
39.95
100D
42.21
0
Volume trend — traded volume by day
18 Sep0L
15 Sep0L
11 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
GOLDLINE PHARMACEUTICAL LIMITE Share Price
GOLDLINE PHARMACEUTICAL LIMITE
Pharmaceuticals
Add Stock
Add Another

GOLDLINE PHARMACEUTICAL LIMITE Share Price FAQs

GOLDLINE PHARMACEUTICAL LIMITE share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837